Emerging Europe

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

See Prices or Subscribe
Emerging Europe

Latest Emerging Europe Analysis

Industry Trend Analysis - Progressive Reimbursement Policies Will Attract Orphan Drugmakers - SEPT 2015

While Slovenia is currently missing crucial elements of the infrastructure needed to manage rare diseases, such as a national registry and broader screening policies, the country presents significant commercial opportunities for orphan drugmakers owing to its progressive reimbursement policies towards orphan drugs and patients with rare diseases.